LivaNova PLC
LIVN
शेयरों में रैंक
#3835
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
शेयर मूल्य
$78.25
अंतिम समन्वयन: 2026-10-21
मार्केट कैप
$4.30B
बदलाव (1 दिन)
-1.84%
बदलाव (1 वर्ष)
42.65%
देश
GB
व्यापार LivaNova PLC (LIVN)
श्रेणी
Healthcare
LivaNova PLC (LIVN) के लिए बकाया शेयरों की संख्या
June 2026 की स्थिति में बकाया शेयरों की संख्या: 55.00M
LivaNova PLC की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 55.00M है। December 2023 के अंत में कंपनी के पास 53.90M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
LivaNova PLC (LIVN) के लिए 2000 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
| वर्ष | बकाया शेयर | परिवर्तन |
|---|---|---|
| 2026 (TTM) | 55.00M | 1.40% |
| 2024 | 54.24M | 0.63% |
| 2023 | 53.90M | 0.75% |
| 2022 | 53.50M | 5.66% |
| 2021 | 50.63M | 4.20% |
| 2020 | 48.59M | 0.50% |
| 2019 | 48.35M | -0.30% |
| 2018 | 48.50M | 0.61% |
| 2017 | 48.20M | -1.35% |
| 2016 | 48.86M | 85.14% |
| 2015 | 26.39M | -2.77% |
| 2014 | 27.14M | -1.67% |
| 2013 | 27.60M | -0.80% |
| 2012 | 27.83M | -0.80% |
| 2011 | 28.05M | 1.26% |
| 2010 | 27.70M | 4.02% |
| 2009 | 26.63M | 0.50% |
| 2008 | 26.50M | 3.86% |
| 2007 | 25.51M | 2.40% |
| 2006 | 24.92M | 3.66% |
| 2005 | 24.04M | 4.10% |
| 2004 | 23.09M | 4.79% |
| 2003 | 22.03M | 1.75% |
| 2002 | 21.66M | 20.01% |
| 2000 | 18.04M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
| कंपनी | बकाया शेयर | अंतर | देश |
|---|---|---|---|
| 1.74B | 3,069.18% |
US
|
|
| 1.28B | 2,231.09% |
IE
|
|
| 383.50M | 597.27% |
US
|
|
| 1.48B | 2,586.55% |
US
|
|
| - | - |
DE
|
